Wegovy
Weekly pen containing semaglutide for weight management in adults with obesity or overweight and comorbidity.
- FormFormFormeVorm
- Solution for injection
So wirkt es:How it works:Mode d’action :Zo werkt het: Semaglutide mimics the body's own gut hormone GLP-1. It acts on appetite centers in the brain, increases the feeling of satiety, and can thus help to eat less. It also slows down gastric emptying.
- If you prefer one injection per week
- If your BMI is 30 or higher, or 27 or higher if you have a weight-related comorbidity
- If you would like to combine the treatment with dietary changes and exercise
Anwendung & wichtige HinweiseUse & important informationUtilisation et informations importantesGebruik en belangrijke aandachtspunten
Anwendung:Use:Utilisation :Gebruik: Once a week, injected subcutaneously into the abdomen, thigh, or upper arm, regardless of meals. Treatment begins with 0,25 mg; the dose is gradually increased every 4 weeks, over a total of approximately 16 weeks (starter and subsequent packs).
Verfügbare Stärken:Available strengths:Dosages disponibles :Beschikbare sterktes: 0,25 mg · 0,5 mg · 1 mg · 1,7 mg · 2,4 mg
Not to be used during pregnancy or breastfeeding. If severe abdominal pain persists, immediate medical attention is necessary, as inflammation of the pancreas is possible.

